{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:25:48Z","timestamp":1792783548850,"version":"4.5.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e0 degli Studi di Napoli Federico II","id":[{"id":"https:\/\/ror.org\/05290cv24","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>The current single-center, retrospective, observational cohort study with a cross-sectional design was conducted to evaluate the association between androgenic profile and metabolic cardiovascular risk (mCVR) factors and to explore whether testosterone deficiency was associated with an unfavourable cardiometabolic profile in a large community-recruited cohort of 659 young men aged 18\u201335 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Participants underwent comprehensive assessment of anthropometric, biochemical, clinical, and hormonal parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Body mass index (BMI), expression of generalized obesity, waist circumference (WC), expression of abdominal\/visceral obesity, diastolic blood pressure (DBP) and triglycerides (TG) significantly and progressively decreased and high-density lipoprotein (HDL)-cholesterol significantly increased across total testosterone (TT) tertiles. Similarly, weight, BMI, WC, systolic blood pressure (SBP), DBP and TG significantly decreased and HDL-cholesterol significantly increased across SHBG tertiles. Weight and adiposity-related anthropometric parameters, namely BMI and WC, significantly and progressively decreased across calculated free testosterone (cFT) tertiles. Spearman correlation analysis showed that TT and SHBG were significantly and negatively correlated with weight (\n                      <jats:italic>r<\/jats:italic>\n                      =-0.149,\n                      <jats:italic>r<\/jats:italic>\n                      =-0.154), BMI (\n                      <jats:italic>r<\/jats:italic>\n                      =-0.204,\n                      <jats:italic>r<\/jats:italic>\n                      =-0.165), WC (\n                      <jats:italic>r<\/jats:italic>\n                      =-0.234,\n                      <jats:italic>r<\/jats:italic>\n                      =-0.225), SBP (\n                      <jats:italic>r<\/jats:italic>\n                      =-0.112,\n                      <jats:italic>r<\/jats:italic>\n                      =-0.142) and TG (\n                      <jats:italic>r<\/jats:italic>\n                      =-0.117,\n                      <jats:italic>r<\/jats:italic>\n                      =-0.204), and significantly and positively correlated with HDL-cholesterol (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.167,\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.251). Additionally, SHBG was significantly and negatively correlated with DBP (\n                      <jats:italic>r<\/jats:italic>\n                      =-0.173). cFT was significantly and negatively correlated with age (\n                      <jats:italic>r<\/jats:italic>\n                      =-0.108) and BMI (\n                      <jats:italic>r<\/jats:italic>\n                      =-0.132). In a multiple linear regression analysis in models adjusted for age, BMI and WC, TT and SHBG were independently associated with HDL-cholesterol (\u03b2\u2009=\u20090.151, \u03b2\u2009=\u20090.186), and SHBG was independently associated with SBP (\u03b2=-0.177) and DBP (\u03b2=-0.204). Men with testosterone below the normal range (Hypo-T group) showed a significantly higher prevalence of generalized obesity and abdominal obesity than men with testosterone within the normal range (Normal-T group). Conversely, Overweight\/Obese men exhibited significantly lower TT and a significantly higher prevalence of testosterone deficiency than Normal-Weight men.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In young adult men, androgenic profile was found to be robustly associated with mCVR factors; however, causality and temporal directionality cannot be inferred because of the cross-sectional design of the study.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s40618-026-03037-5","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:16:23Z","timestamp":1791267383000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The association between androgenic profile and cardiometabolic risk factors in young men: insights from a large observational cohort study"],"prefix":"10.1007","author":[{"given":"Davide","family":"Menafra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"de Angelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Garifalos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Chiodini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nunzia","family":"Verde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela","family":"Piscopo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Galdiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"De Fraia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Mazzarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Di Paola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Simeoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariarosaria","family":"Negri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Pivonello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Giannella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Zarrilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Colao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9632-1348","authenticated-orcid":false,"given":"Rosario","family":"Pivonello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"issue":"22","key":"3037_CR1","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1016\/j.jacc.2025.08.015","volume":"86","author":"C Risks","year":"2025","unstructured":"Global Burden of Cardiovascular, D. and, Risks C (2025) Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990\u20132023. J Am Coll Cardiol 86(22):2167\u20132243","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"3037_CR2","doi-asserted-by":"publisher","first-page":"e039239","DOI":"10.1161\/JAHA.124.039239","volume":"14","author":"J Scott","year":"2025","unstructured":"Scott J et al (2025) Cardiovascular Health in the Transition From Adolescence to Emerging Adulthood: A Scientific Statement From the American Heart Association. J Am Heart Assoc 14(9):e039239","journal-title":"J Am Heart Assoc"},{"issue":"18","key":"3037_CR3","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1001\/archinternmed.2012.3310","volume":"172","author":"A Damasceno","year":"2012","unstructured":"Damasceno A et al (2012) The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries. Arch Intern Med 172(18):1386\u20131394","journal-title":"Arch Intern Med"},{"issue":"8","key":"3037_CR4","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1177\/2047487317689974","volume":"24","author":"M Lindgren","year":"2017","unstructured":"Lindgren M et al (2017) Cardiorespiratory fitness and muscle strength in late adolescence and long-term risk of early heart failure in Swedish men. Eur J Prev Cardiol 24(8):876\u2013884","journal-title":"Eur J Prev Cardiol"},{"issue":"5","key":"3037_CR5","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jchf.2016.11.014","volume":"5","author":"A Pandey","year":"2017","unstructured":"Pandey A et al (2017) Fitness in Young Adulthood and Long-Term Cardiac Structure and Function: The CARDIA Study. JACC Heart Fail 5(5):347\u2013355","journal-title":"JACC Heart Fail"},{"issue":"1","key":"3037_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1001\/jamainternmed.2015.6309","volume":"176","author":"RV Shah","year":"2016","unstructured":"Shah RV et al (2016) Association of Fitness in Young Adulthood With Survival and Cardiovascular Risk: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. JAMA Intern Med 176(1):87\u201395","journal-title":"JAMA Intern Med"},{"issue":"4","key":"3037_CR7","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nrcardio.2017.154","volume":"15","author":"C Andersson","year":"2018","unstructured":"Andersson C, Vasan RS (2018) Epidemiology of cardiovascular disease in young individuals. Nat Rev Cardiol 15(4):230\u2013240","journal-title":"Nat Rev Cardiol"},{"issue":"10","key":"3037_CR8","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","volume":"135","author":"EJ Benjamin","year":"2017","unstructured":"Benjamin EJ et al (2017) Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation 135(10):e146\u2013e603","journal-title":"Circulation"},{"issue":"1","key":"3037_CR9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41367-019-0008-2","volume":"9","author":"G Bellastella","year":"2019","unstructured":"Bellastella G et al (2019) How much does obesity affect the male reproductive function? Int J Obes Suppl 9(1):50\u201364","journal-title":"Int J Obes Suppl"},{"key":"3037_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3389\/fendo.2019.00345","volume":"10","author":"R Pivonello","year":"2019","unstructured":"Pivonello R et al (2019) Metabolic Disorders and Male Hypogonadotropic Hypogonadism. Front Endocrinol (Lausanne) 10:345","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3037_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000360553","volume":"43","author":"DM Kelly","year":"2014","unstructured":"Kelly DM, Jones TH (2014) Testosterone and cardiovascular risk in men. Front Horm Res 43:1\u201320","journal-title":"Front Horm Res"},{"issue":"1","key":"3037_CR12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1743-6109.2008.01059.x","volume":"6","author":"G Corona","year":"2009","unstructured":"Corona G et al (2009) Pulse pressure, an index of arterial stiffness, is associated with androgen deficiency and impaired penile blood flow in men with ED. J Sex Med 6(1):285\u2013293","journal-title":"J Sex Med"},{"issue":"2","key":"3037_CR13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1210\/er.2001-0025","volume":"24","author":"FC Wu","year":"2003","unstructured":"Wu FC, von Eckardstein A (2003) Androgens and coronary artery disease. Endocr Rev 24(2):183\u2013217","journal-title":"Endocr Rev"},{"issue":"5","key":"3037_CR14","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1530\/EJE-09-0052","volume":"160","author":"M Yaron","year":"2009","unstructured":"Yaron M et al (2009) Effect of testosterone replacement therapy on arterial stiffness in older hypogonadal men. Eur J Endocrinol 160(5):839\u2013846","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"3037_CR15","doi-asserted-by":"publisher","first-page":"e100409","DOI":"10.1371\/journal.pone.0100409","volume":"9","author":"JS Brand","year":"2014","unstructured":"Brand JS et al (2014) Testosterone, sex hormone-binding globulin and the metabolic syndrome in men: an individual participant data meta-analysis of observational studies. PLoS ONE 9(7):e100409","journal-title":"PLoS ONE"},{"issue":"11","key":"3037_CR16","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1001\/jama.295.11.1288","volume":"295","author":"EL Ding","year":"2006","unstructured":"Ding EL et al (2006) Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 295(11):1288\u20131299","journal-title":"JAMA"},{"issue":"9","key":"3037_CR17","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1210\/jc.2008-0054","volume":"93","author":"V Kupelian","year":"2008","unstructured":"Kupelian V et al (2008) Inverse association of testosterone and the metabolic syndrome in men is consistent across race and ethnic groups. J Clin Endocrinol Metab 93(9):3403\u20133410","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"3037_CR18","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1210\/jc.2005-1326","volume":"91","author":"V Kupelian","year":"2006","unstructured":"Kupelian V et al (2006) Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab 91(3):843\u2013850","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"3037_CR19","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.2337\/diacare.27.5.1036","volume":"27","author":"DE Laaksonen","year":"2004","unstructured":"Laaksonen DE et al (2004) Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 27(5):1036\u20131041","journal-title":"Diabetes Care"},{"issue":"1","key":"3037_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2337\/diacare.25.1.55","volume":"25","author":"JY Oh","year":"2002","unstructured":"Oh JY et al (2002) Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study. Diabetes Care 25(1):55\u201360","journal-title":"Diabetes Care"},{"key":"3037_CR21","doi-asserted-by":"crossref","unstructured":"Kaplan SA, Meehan AG, Shah A (2006) The age related decrease in testosterone is significantly exacerbated in obese men with the metabolic syndrome. What are the implications for the relatively high incidence of erectile dysfunction observed in these men? J Urol, 176(4 Pt 1): pp. 1524-7; discussion 1527-8","DOI":"10.1016\/j.juro.2006.06.003"},{"issue":"11","key":"3037_CR22","doi-asserted-by":"publisher","first-page":"5462","DOI":"10.1210\/jc.2004-0804","volume":"89","author":"S Dhindsa","year":"2004","unstructured":"Dhindsa S et al (2004) Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. J Clin Endocrinol Metab 89(11):5462\u20135468","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"3037_CR23","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1210\/jc.2007-2177","volume":"93","author":"M Grossmann","year":"2008","unstructured":"Grossmann M et al (2008) Low testosterone levels are common and associated with insulin resistance in men with diabetes. J Clin Endocrinol Metab 93(5):1834\u20131840","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"3037_CR24","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1210\/jc.2004-0970","volume":"90","author":"DE Laaksonen","year":"2005","unstructured":"Laaksonen DE et al (2005) The metabolic syndrome and smoking in relation to hypogonadism in middle-aged men: a prospective cohort study. J Clin Endocrinol Metab 90(2):712\u2013719","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"3037_CR25","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S2213-8587(24)00199-2","volume":"12","author":"NL De Silva","year":"2024","unstructured":"De Silva NL et al (2024) Male hypogonadism: pathogenesis, diagnosis, and management. Lancet Diabetes Endocrinol 12(10):761\u2013774","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"3037_CR26","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1093\/sxmrev\/qeaf036","volume":"13","author":"M Khera","year":"2025","unstructured":"Khera M et al (2025) Male hypogonadism: recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024). Sex Med Rev 13(4):548\u2013573","journal-title":"Sex Med Rev"},{"issue":"6","key":"3037_CR27","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1093\/ejendo\/lvae128","volume":"191","author":"C Miller","year":"2024","unstructured":"Miller C et al (2024) Mechanisms in endocrinology: hypogonadism and metabolic health in men-novel insights into pathophysiology. Eur J Endocrinol 191(6):R1\u2013R17","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"3037_CR28","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/j.1365-2265.2010.03845.x","volume":"73","author":"SY Kalinchenko","year":"2010","unstructured":"Kalinchenko SY et al (2010) Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study. Clin Endocrinol (Oxf) 73(5):602\u2013612","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"3037_CR29","first-page":"991","volume":"16","author":"P Marin","year":"1992","unstructured":"Marin P et al (1992) The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes Relat Metab Disord 16(12):991\u2013997","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"6","key":"3037_CR30","first-page":"329","volume":"1","author":"P Marin","year":"1992","unstructured":"Marin P, Krotkiewski M, Bjorntorp P (1992) Androgen treatment of middle-aged, obese men: effects on metabolism, muscle and adipose tissues. Eur J Med 1(6):329\u2013336","journal-title":"Eur J Med"},{"issue":"1","key":"3037_CR31","first-page":"239","volume":"80","author":"P Marin","year":"1995","unstructured":"Marin P, Oden B, Bjorntorp P (1995) Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens. J Clin Endocrinol Metab 80(1):239\u2013243","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"3037_CR32","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/01485010701730880","volume":"53","author":"F Saad","year":"2007","unstructured":"Saad F et al (2007) An exploratory study of the effects of 12 month administration of the novel long-acting testosterone undecanoate on measures of sexual function and the metabolic syndrome. Arch Androl 53(6):353\u2013357","journal-title":"Arch Androl"},{"issue":"1","key":"3037_CR33","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2164\/jandrol.107.002774","volume":"29","author":"F Saad","year":"2008","unstructured":"Saad F et al (2008) A dose-response study of testosterone on sexual dysfunction and features of the metabolic syndrome using testosterone gel and parenteral testosterone undecanoate. J Androl 29(1):102\u2013105","journal-title":"J Androl"},{"issue":"1","key":"3037_CR34","doi-asserted-by":"publisher","first-page":"146","DOI":"10.4103\/1008-682X.122346","volume":"16","author":"X Cai","year":"2014","unstructured":"Cai X et al (2014) Metabolic effects of testosterone replacement therapy on hypogonadal men with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. Asian J Androl 16(1):146\u2013152","journal-title":"Asian J Androl"},{"issue":"6 Pt 1","key":"3037_CR35","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/j.1365-2605.2010.01117.x","volume":"34","author":"G Corona","year":"2011","unstructured":"Corona G et al (2011) Type 2 diabetes mellitus and testosterone: a meta-analysis study. Int J Androl 34(6 Pt 1):528\u2013540","journal-title":"Int J Androl"},{"issue":"4","key":"3037_CR36","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.beem.2013.05.002","volume":"27","author":"G Corona","year":"2013","unstructured":"Corona G, Rastrelli G, Maggi M (2013) Diagnosis and treatment of late-onset hypogonadism: systematic review and meta-analysis of TRT outcomes. Best Pract Res Clin Endocrinol Metab 27(4):557\u2013579","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"6","key":"3037_CR37","doi-asserted-by":"publisher","first-page":"726","DOI":"10.2164\/jandrol.108.007005","volume":"30","author":"AE Heufelder","year":"2009","unstructured":"Heufelder AE et al (2009) Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone. J Androl 30(6):726\u2013733","journal-title":"J Androl"},{"issue":"4","key":"3037_CR38","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1001\/jamainternmed.2023.7862","volume":"184","author":"S Bhasin","year":"2024","unstructured":"Bhasin S et al (2024) Effect of Testosterone on Progression From Prediabetes to Diabetes in Men With Hypogonadism: A Substudy of the TRAVERSE Randomized Clinical Trial. JAMA Intern Med 184(4):353\u2013362","journal-title":"JAMA Intern Med"},{"issue":"1","key":"3037_CR39","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.atherosclerosis.2012.02.020","volume":"222","author":"S Firtser","year":"2012","unstructured":"Firtser S et al (2012) Relation of total and free testosterone and sex hormone-binding globulin with cardiovascular risk factors in men aged 24\u201345 years. The Cardiovascular Risk in Young Finns Study. Atherosclerosis 222(1):257\u2013262","journal-title":"Atherosclerosis"},{"issue":"10 Pt 1","key":"3037_CR40","first-page":"1041","volume":"11","author":"SM Gapstur","year":"2002","unstructured":"Gapstur SM et al (2002) Serum androgen concentrations in young men: a longitudinal analysis of associations with age, obesity, and race. The CARDIA male hormone study. Cancer Epidemiol Biomarkers Prev 11(10 Pt 1):1041\u20131047","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"19","key":"3037_CR41","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","author":"Expert Panel on Detection","year":"2001","unstructured":"Expert Panel on Detection (2001) Treatment of High Blood Cholesterol in, Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285(19):2486\u20132497","journal-title":"JAMA"},{"issue":"17","key":"3037_CR42","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"Grundy SM et al (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112(17):2735\u20132752","journal-title":"Circulation"},{"issue":"10","key":"3037_CR43","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","volume":"84","author":"A Vermeulen","year":"1999","unstructured":"Vermeulen A, Verdonck L, Kaufman JM (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84(10):3666\u20133672","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"3037_CR44","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1210\/jc.2018-00229","volume":"103","author":"S Bhasin","year":"2018","unstructured":"Bhasin S et al (2018) Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 103(5):1715\u20131744","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"3037_CR45","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/andr.12770","volume":"8","author":"G Corona","year":"2020","unstructured":"Corona G et al (2020) European Academy of Andrology (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males: Endorsing organization: European Society of Endocrinology. Andrology 8(5):970\u2013987","journal-title":"Andrology"},{"issue":"12","key":"3037_CR46","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1007\/s40618-022-01859-7","volume":"45","author":"AM Isidori","year":"2022","unstructured":"Isidori AM et al (2022) Adult- and late-onset male hypogonadism: the clinical practice guidelines of the Italian Society of Andrology and Sexual Medicine (SIAMS) and the Italian Society of Endocrinology (SIE). J Endocrinol Invest 45(12):2385\u20132403","journal-title":"J Endocrinol Invest"},{"key":"3037_CR47","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000485999","volume":"49","author":"G Rastrelli","year":"2018","unstructured":"Rastrelli G et al (2018) Metabolic Syndrome in Male Hypogonadism. Front Horm Res 49:131\u2013155","journal-title":"Front Horm Res"},{"issue":"6","key":"3037_CR48","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1111\/j.1365-2265.2011.03987.x","volume":"74","author":"MH Gannage-Yared","year":"2011","unstructured":"Gannage-Yared MH, Chedid R, Abs L (2011) Relation between androgens and cardiovascular risk factors in a young population. Clin Endocrinol (Oxf) 74(6):720\u2013725","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"3037_CR49","doi-asserted-by":"publisher","first-page":"e1002805","DOI":"10.1371\/journal.pgen.1002805","volume":"8","author":"AD Coviello","year":"2012","unstructured":"Coviello AD et al (2012) A genome-wide association meta-analysis of circulating sex hormone-binding globulin reveals multiple Loci implicated in sex steroid hormone regulation. PLoS Genet 8(7):e1002805","journal-title":"PLoS Genet"},{"issue":"7","key":"3037_CR50","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.tem.2015.05.001","volume":"26","author":"R Simo","year":"2015","unstructured":"Simo R et al (2015) Novel insights in SHBG regulation and clinical implications. Trends Endocrinol Metab 26(7):376\u2013383","journal-title":"Trends Endocrinol Metab"},{"issue":"11","key":"3037_CR51","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.2337\/dc11-0888","volume":"34","author":"S Bhasin","year":"2011","unstructured":"Bhasin S et al (2011) Sex hormone-binding globulin, but not testosterone, is associated prospectively and independently with incident metabolic syndrome in men: the framingham heart study. Diabetes Care 34(11):2464\u20132470","journal-title":"Diabetes Care"},{"issue":"6","key":"3037_CR52","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1530\/EJE-13-1046","volume":"170","author":"D Canoy","year":"2014","unstructured":"Canoy D et al (2014) Serum sex hormone-binding globulin and testosterone in relation to cardiovascular disease risk factors in young men: a population-based study. Eur J Endocrinol 170(6):863\u2013872","journal-title":"Eur J Endocrinol"},{"key":"3037_CR53","doi-asserted-by":"publisher","first-page":"117863882311550","DOI":"10.1177\/11786388231155006","volume":"16","author":"A Mohammadrezaei","year":"2023","unstructured":"Mohammadrezaei A et al (2023) Association Between Sex Hormone-Binding Globulin, Atherogenic Indices of Plasma Among Young Sedentary Males. Nutr Metab Insights 16:11786388231155006","journal-title":"Nutr Metab Insights"},{"issue":"2","key":"3037_CR54","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.atherosclerosis.2004.10.029","volume":"179","author":"V Bataille","year":"2005","unstructured":"Bataille V et al (2005) Sex hormone-binding globulin is a major determinant of the lipid profile: the PRIME study. Atherosclerosis 179(2):369\u2013373","journal-title":"Atherosclerosis"},{"issue":"4","key":"3037_CR55","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/cen.13530","volume":"88","author":"G Rastrelli","year":"2018","unstructured":"Rastrelli G et al (2018) Sex hormone-binding globulin is associated with androgen deficiency features independently of total testosterone. Clin Endocrinol (Oxf) 88(4):556\u2013564","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"3037_CR56","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1530\/EJE-07-0893","volume":"158","author":"SA Chubb","year":"2008","unstructured":"Chubb SA et al (2008) Lower sex hormone-binding globulin is more strongly associated with metabolic syndrome than lower total testosterone in older men: the Health in Men Study. Eur J Endocrinol 158(6):785\u2013792","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"3037_CR57","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1056\/NEJMoa0804381","volume":"361","author":"EL Ding","year":"2009","unstructured":"Ding EL et al (2009) Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med 361(12):1152\u20131163","journal-title":"N Engl J Med"},{"key":"3037_CR58","unstructured":"EpiCentro - L\u2019epidemiologia per la sanit\u00e0 pubblica. Sovrappeso e obesit\u00e0: dati sorveglianza PASSI. Istituto Superiore di Sanit\u00e0"},{"issue":"2","key":"3037_CR59","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0026-0495(97)90299-7","volume":"46","author":"ME Ramirez","year":"1997","unstructured":"Ramirez ME et al (1997) Evidence for sex steroid inhibition of lipoprotein lipase in men: comparison of abdominal and femoral adipose tissue. Metabolism 46(2):179\u2013185","journal-title":"Metabolism"},{"issue":"2","key":"3037_CR60","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1046\/j.1365-2265.1998.3721211.x","volume":"48","author":"KC Tan","year":"1998","unstructured":"Tan KC et al (1998) Effects of testosterone replacement on HDL subfractions and apolipoprotein A-I containing lipoproteins. Clin Endocrinol (Oxf) 48(2):187\u2013194","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"3037_CR61","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.mce.2013.09.017","volume":"382","author":"A Morelli","year":"2014","unstructured":"Morelli A et al (2014) Metabolic syndrome induces inflammation and impairs gonadotropin-releasing hormone neurons in the preoptic area of the hypothalamus in rabbits. Mol Cell Endocrinol 382(1):107\u2013119","journal-title":"Mol Cell Endocrinol"},{"issue":"11","key":"3037_CR62","doi-asserted-by":"publisher","first-page":"4868","DOI":"10.1210\/en.2003-0644","volume":"144","author":"H Watanobe","year":"2003","unstructured":"Watanobe H, Hayakawa Y (2003) Hypothalamic interleukin-1 beta and tumor necrosis factor-alpha, but not interleukin-6, mediate the endotoxin-induced suppression of the reproductive axis in rats. Endocrinology 144(11):4868\u20134875","journal-title":"Endocrinology"},{"issue":"2","key":"3037_CR63","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/andr.13367","volume":"11","author":"G Corona","year":"2023","unstructured":"Corona G et al (2023) Testosterone therapy in diabetes and pre-diabetes. Andrology 11(2):204\u2013214","journal-title":"Andrology"},{"issue":"1","key":"3037_CR64","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S2213-8587(20)30367-3","volume":"9","author":"G Wittert","year":"2021","unstructured":"Wittert G et al (2021) Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial. Lancet Diabetes Endocrinol 9(1):32\u201345","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"3037_CR65","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJMoa1000485","volume":"363","author":"S Basaria","year":"2010","unstructured":"Basaria S, Coviello AD, Travison TG et al (2010) Adverse events associated with testosterone administration. N Engl J Med 363(2):109\u2013122. https:\/\/doi.org\/10.1056\/NEJMoa1000485","journal-title":"N EnglJ Med"},{"issue":"17","key":"3037_CR66","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1001\/jama.2013.280386","volume":"310","author":"R Vigen","year":"2013","unstructured":"Vigen R, O\u2019Donnell CI, Bar\u00f3n AE et al (2013) Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA 310(17):1829\u20131836. https:\/\/doi.org\/10.1001\/jama.2013.280386","journal-title":"JAMA"},{"issue":"1","key":"3037_CR67","doi-asserted-by":"publisher","first-page":"e85805","DOI":"10.1371\/journal.pone.0085805","volume":"9","author":"WD Finkle","year":"2014","unstructured":"Finkle WD, Greenland S, Ridgeway GK et al (2014) Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men. PLoS ONE 9(1):e85805. https:\/\/doi.org\/10.1371\/journal.pone.0085805","journal-title":"PLoS ONE"},{"issue":"2","key":"3037_CR68","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa2215025","volume":"389","author":"AM Lincoff","year":"2023","unstructured":"Lincoff AM, Bhasin S, Flevaris P et al (2023) TRAVERSE Study Investigators. Cardiovascular safety of testosterone-replacement therapy. N Engl J Med 389(2):107\u2013117. https:\/\/doi.org\/10.1056\/NEJMoa2215025","journal-title":"N Engl J Med"},{"key":"3037_CR69","doi-asserted-by":"crossref","unstructured":"Tienforti D et al (2026) Testosterone replacement therapy and cardiovascular safety in older men: lessons from TRAVERSE and beyond. J Endocrinol Invest","DOI":"10.1007\/s40618-026-02945-w"},{"issue":"11","key":"3037_CR70","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1007\/s40618-023-02136-x","volume":"46","author":"DG Corona","year":"2023","unstructured":"Corona DG et al (2023) Metabolic syndrome and erectile dysfunction: a systematic review and meta-analysis study. J Endocrinol Invest 46(11):2195\u20132211","journal-title":"J Endocrinol Invest"},{"issue":"16","key":"3037_CR71","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1080\/14656566.2024.2422547","volume":"25","author":"G Corona","year":"2024","unstructured":"Corona G et al (2024) Pharmacotherapeutic strategies for the management of erectile dysfunction in patients with diabetes and pre-diabetes. Expert Opin Pharmacother 25(16):2213\u20132223","journal-title":"Expert Opin Pharmacother"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-03037-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-026-03037-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-03037-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:02:36Z","timestamp":1791270156000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-026-03037-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":71,"alternative-id":["3037"],"URL":"https:\/\/doi.org\/10.1007\/s40618-026-03037-5","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"assertion":[{"value":"14 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":1,"name":"Ethics","label":"<b>Conflict of interests<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the local Ethics Committee.","order":2,"name":"Ethics","label":"<b>Ethics approval<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","label":"<b>Consent to participate<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}}]}}